OF HEPATIC PERFUSION DISORDERS I MARZOUK MOUSSA F KSONTINI L BEN FARHAT A MANAMANI N DALI L HENDAOUI MEDICAL IMAGING AND INTERVENTIONNAL DEPARTEMENT MONGI SLIM HOSPITAL LA MARSA TUNISIA GI12 ID: 424797
Download Presentation The PPT/PDF document "COMPUTED TOMOGRAPHY EVALUATION" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
COMPUTED TOMOGRAPHY EVALUATION OF HEPATIC PERFUSION DISORDERS
I MARZOUK MOUSSA, F KSONTINI, L BEN FARHAT, A MANAMANI, N DALI, L HENDAOUIMEDICAL IMAGING AND INTERVENTIONNAL DEPARTEMENT, MONGI SLIM HOSPITAL, LA MARSA TUNISIA
GI12Slide2
Introduction
The liver has a dual blood supply , which comes from the hepatic artery ( 25% of vascularization) and the portal vein ( 75% of vascularization).There are several communications between both systems including hepatic sinusoids and peribiliary
plexus . when vascular compromise of hepatic blood supply or venous drainage occurs ,control systems intervene inducing in imaging abnormalities of parenchymal
enhancement time varying.Slide3
These hepatic perfusion disorders
(HPD) can be detected with multiphases computed tomography imaging
through the study of the parenchymal
enhacement kinetic.HPD are
commonly
associated
with
changes in
arterial
, portal or
venous
flow and
sometimes
have mixed
origin
.Slide4
Material and Methods
A retrospective study including seven patients with
hepatic perfusion disorders :
hepatic abscess Rendu-Osler disease
Pancreatic head cancer with an hepatic
hilar
lymph node compressing the hepatic artery
Budd Chiari syndrome
Superior vena cava thrombosis
Hepatic cirrhosis
Thrombosis of the left portal branch.Slide5
Results
Arterial origin Arterial occlusion :
It rarely induces hepatic
perfusion disorders in imaging except in case of:
*
Thrombosis
of
hepatic
artery
in transplantation
*An
associeted
venous
occlusion (figure 3 ) .Slide6
CT findings :
a triangular segmentary or lobar hypodensity persisting in different phases of Iodin contrast
injection with hilar somet and
peripheral base . Intrahepatic bile
ducts
are sensitive to
arterial
ischemia
and
may
necrose giving biliar false cyst.
Arterial origin Slide7
Figure 3 :Lymphadenopathy
of hepatic hilum () secondary to cancer of pancreas own
tail ()
, compressing the hepatic artery
and the portal
vein
causing
HPD of the
left
liver
()
Arterial origin Slide8
Arterial flow increase
:Hypervascular tumor .Intense inflammatory reaction ( figure 1) .Hereditary
Hemorrhagic Telangiectasia (HHT) called Disease
of Rendu_Osler (figure 2) .
Arterial originSlide9
Figure 1
:Hepatic abcess of segment II and III ( ) ,
surrounded by an abnormal enhacement of the
hepatic parenchyma (
)
Arterial originSlide10
HHT is a vascular disease with autosomal
dominant transmission characterized by multiple telangiectases.It affects mucocutaneous tissue most frequently, but any part of the body can be affected including the liver traduced by numerous arteriovenous shunts between hepatic artery branches and branches of the hepatic or portal veins.
Arterial
originSlide11
Figure 2
: Disease of Rendu _Osler : significant increase
of the caliber of the hepatic
artery (
)
and
its
branches
with
many
arteriovenous fistulas and abnormal
parenchymal
enhacement of
left liver ()
.
Arterial originSlide12
Portal origin
HPD are often caused by venous inflow obstruction due to portal vein thrombosis , tumor invasion ,compression or surgical ligation .The causes of portal vein thrombosis include neoplasm that invades or compresses the portal system , infection process , embolisation , hypercoagulative states and myeloproliferative disorders.Slide13
CT findings : intense enhacement of the hypoperfused parenchyma in hepati arterial phase images ( explicated
by arterial flow increase ) that returns
to normal in portal phase .
Figure 4:
Abnormal
contrast
inhacement
of the
left
liver
caused
by thrombosis of the ipsilateral
portal branch.
Potal originSlide14
Venous
origin Cardiac liver .Budd Chiari syndrome ( figure 5).
CT findings :
hypoperfusion of peripheral parenchyma
contrasting
with
a normal perfusion of the central
parenchyma
.Slide15
Budd-Chiari syndrome is defined as lobar or segmental hepatic venous outflow obstruction at the level of the hepatic veins or inferior vena cava (IVC) and may be primary or secondary .
This Hepatic venous outflow obstruction leads to elevation of sinusoidal pressure and diminished portal venous flow, which culminates in centrilobular congestion followed by necrosis and atrophy.
Venous originSlide16
Figure
5 Budd Chiari syndrome : significant hapertrophy of segment I (←
) that normally
inhace contrasting with the
peripheral
parenchyme
which
remains
hypodense
(
).
Venous originSlide17
Mixed origin
Arterio portal fistula
(APF) :An APF is
an organic or a functionnal communication between an arterial
hepatic
branch
and the portal
venous
system ,
resulting
in redistribution of arterial flow into a focal region of portal venous flow .
The causes of APF
include
:
liver cirrhosis (figure 6) , hepato cellular carcinoma , iatrogenic
fistulae after liver biopsy ,
traumatic or spontaneous fistulae .Slide18
Figure
6 :
Hepatic cirrhosis :
Early enhacement of segment III (
)
that
is
irregularly
shaped , non systematized , with opacification of the
left
portal
branch in
arterial phases through an arterio portal fistula
.Mixed
originSlide19
Superior
vena cava obstruction : A reflux through arterio portal collateral inheritance rarely
used ( figure 7) .
Figure 7:
Intense opacification of segment III (
)
on portal phase
through
arterio
portal
collateral
inheritances
secondary to
superior vena cava thrombosis.
Mixed originSlide20
Discussion
Hepatic diffuse diseases ,benign conditions and malignant tumors
are commonly associeted with changes in
arterial , portal or hepatic venous flow, detected
in
imaging
by
abnormal
parenchymal
enhacement
after iodin contrast injection ; which
can
be
inerpreted as false positives and negatives in tumor detect and
staging.Slide21
The mechanism can
be obstruction , fistulae or compression .Such images are very common : thrombosis of the portal branch induces an early
parenchymal enhancement disappearing in portal phase. Arterial obstruction induces segmentary or lobar hypodensity persisting in different phases of
iodin contrast injection . Slide22
Arterio_portal fistulae can be mistaken with hypervascular tumors or intense inflammatory reaction.
Cardiac liver and Budd Chiari syndrome induces a normal enhancement of the central parenchyma contrasting with a low enhancement in the peripheral tissue.Slide23
Conclusion
The study of different aspects of hepatic perfusion disorders which are sometimes misleading allows to not confuse them with organic hepatic lesion.